![]() |
Market Research Report
Global Dietary Supplements Market Forecast 2019-2028 |
||||||
Published by | Inkwood Research | Product code | 980909 | ||||
Published | Content info | 248 Pages Delivery time: 2-3 business days |
|||||
Price |
|
Global Dietary Supplements Market Forecast 2019-2028 | ||
Published: January 11, 2021 | Content info: 248 Pages |
|
The global dietary supplements market is set to record a CAGR of 9.26% during the forecast period, 2019-2028. The factors influencing the growth of the market are the rising demand for supplements in the health & wellness industry, the growing prominence of sports nutrition, the trend of active living, the increasing demand for nutraceutical products, etc.
Dietary supplements are products rich in minerals, vitamins, enzymes, herbs, amino acids, etc. Their primary aim is to meet the nutritional needs so as to prevent diseases. Active living is a growing trend across the globe. An unhealthy diet is one of the several reasons for the increased risk of cancer, obesity, diabetes, and cardiovascular diseases. There is an increasing awareness regarding dietary and nutrient supplements, along with an increasing preference for healthy & active living. Countries like the UK, France, Italy, etc., witness increased demands for food supplements. This is because there is an increasing focus on preventing illness or disease over the absence of disease. Also, the rising popularity of organic & herbal products is contributing to market growth. However, regulatory concerns, easy availability of counterfeit products, and growing demand for functional foods, are hindering the market growth.
The global dietary supplements market's geographical growth analysis includes the assessment of North America, Europe, Asia Pacific, and rest of world. The Asia Pacific region is set to harbor the largest market share in the global market by 2028. The ample availability of raw materials, along with the rising geriatric population, benefits the growth of the region.
The market is highly competitive, with a large number of manufacturers. Companies are projected to increase expenditure for establishing strategic partnerships with retail chain companies. Some of the eminent companies in the market are Bayer AG, Abbott Laboratories, GlaxoSmithKline Plc, Herbalife Ltd, Glanbia Plc, etc.